Harris Matthew Scott bought ALT
July 31, 2025 · Form 4 insider transaction
Harris Matthew Scott bought 2,018 shares of Altimmune, Inc. at $3.14 per share, a transaction worth $6.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,018
Price
$3.14
Total value
$6.3K
InsiderHarris Matthew Scott
Role—
CompanyAltimmune, Inc. (ALT)
SecurityCommon Stock, par value $0.0001
Transaction codeA: Grant or award
Transaction dateJuly 31, 2025
Filing dateAugust 4, 2025
Shares owned after16,087
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were purchased due to participation of the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2025 through July 31, 2025.; In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock.